Skip to main content
Log in

Assessment of nausea

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

In a standardized way three different methods of measuring nausea have been assessed in 849 patients enrolled in 4 double blind, randomized, clinical trials, and 2 observational studies. Nausea was measured before and 2, 4, 6, 8 and 24 hours after cancer chemotherapy by using a discrete scale (DS), a visual analogue scale (VAS) and a continuous chromatic analogue scale (ACCS), and it was evaluated according to 4 different dimensions: maximal intensity (MI) entity (E) duration (D) and quantity (Q).

The distributions of nausea measurements in the population, agreement between the scales and their sensitivity, and agreement between dimensions and their sensitivity were analyzed.

A uniform distribution of nausea measurements was found only in patients receiving chemotherapy without any antiemetic treatment. There was substantial equivalence of the different scales, and no advantage was shown an using an analogue (VAS) than a discrete (DS) scale.

A trend toward increasing sensitivity in detecting differences as the dimensions of nausea considered became more inclusive of the various aspects of this symptom (Q more sensible than E more sensible than MI) was observed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Olver IN, Simon RM, Aisner J (1986) Antiemetics studies: a methodological discussion. Cancer Treat Rep 70: 555–563

    Google Scholar 

  2. Lazlo J (1983) Methods for measuring clinical effectiveness of antiemetics. In Antiemetics and Cancer Chemotherapy (Lazlo J, ed). Williams and Wilkins, Baltimore

    Google Scholar 

  3. Morrow GR (1984) The assessment of nausea and vomiting. Past problems, current issues, and suggestion for future research. Cancer 53: (Suppl) 2267–2278

    Google Scholar 

  4. Roila F, Tonato M, Basurto C, Canaletti R, Morsia O, Passalacqua R, Di Costanzo F, Donati D, Colombo N, Ballatori E, Del Favero A, Tognoni G, Franzosi MG (1985) Antiemetic activity of two different high doses of metoclopramide in cisplatin treated cancer patients: a randomized double-blind trial of the Italian Oncology Gruop for Clinical Research. Cancer Treat Rep 69: 1353–1357

    Google Scholar 

  5. Roila F, Tonato M, Basurto C, Bella M, Passalacqua R, Morsia D, Di Costanzo F, Donati D, Ballatori E, Tognoni G, Franzosi MG, Del Favero A (1987) Antiemetic activity of high doses of metoclopramide (MTC) combined with methylprednisolone (P) versus MTC alone in cisplatin treated cancer patients. A randomized double blind trial of the Italian Oncology Group for Clinical Research (GOIRC). J Clin Oncol 5: 141–149

    Google Scholar 

  6. Roila F, Tonato M, Basurto C, Minotti V, Ballatori E, Del Favero A (1987) Double-blind controlled trial of the antiemetic efficacy and toxicity of methylprednisolone (MP), metoclopramide (MTC) and domperidone (DMP) in breast cancer patients treated with I. V. CMF. Eur J Clin Oncol 23: 615–617

    Google Scholar 

  7. Roila F, Tonato M, Basurto C, Picciafuoco M, Bracarda S, Donati D, Malacarne P, Monici L, Di Costanzo F, Patoia L, Ballatori E, Tognoni G, Del Favero A (1989) Protection from nausea and vomiting in Cisplatin-treated patients: High-dose Metoclopramide combined with Methylprednisolone versus Metoclospramide combined with dexamethasone and Diphenhydramine: a study of the Italian Oncology Group for Clinical Research. J Clin Oncol 7: 1693–1700

    Google Scholar 

  8. Grossi E, Borghi C, Cerchiari EL, Della Puppa T, Francucci B (1983) Analogue chromatic continuous scale (ACCS): a new method for pain assessment. Clin Exp Rheumatol 1: 337–340

    Google Scholar 

  9. Bishop JF, Olver IN, Wolf M, Matthews JP, Long M, Bingham J, Hillcoat L, Cooper IA (1984) Lorazepam: a randomized double blind cross over study in patients receiving cytotoxic chemotherapy. J Clin Oncol 2: 691–695

    Google Scholar 

  10. Littman GS, Walker BR, Schneider BE (1985) Reassessment of verbal and visual analogue ratings in analgesic studies. Clin Pharmacol Ther 38: 16–23

    Google Scholar 

  11. Ohnhaus EE, Adler R (1975) Methodological problems in the measurement of pain: a comparison between the verbal rating scale and the visual analogue scale. Pain 7: 379–384

    Google Scholar 

  12. Wallestein SL, Heidrich G, Kaiko R (1980) Clinical evaluation of mild analgesic: the measurement of clinical pain. Br J Clin Pharmacol 10: 3195–3275

    Google Scholar 

  13. Altman DG, Bland JM (1983) Measurement in medicine: the analysis of method comparison studies. The statistician 32: 307–317

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Del Favero, A., Roila, F., Basurto, C. et al. Assessment of nausea. Eur J Clin Pharmacol 38, 115–120 (1990). https://doi.org/10.1007/BF00265968

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00265968

Key words

Navigation